Documents released Wednesday by FDA clarifies the agency will continue to lead the regulatory review of intentional genomic alterations in animals, with information-sharing from the Agriculture Department on some products. The agency also released updated guidance for the industry on the risk-based approach and approval process of these products.
The Center for Veterinary Medicine at the Food and Drug Administration outlined four objectives in an innovation agenda released Friday on how it will address hot issues such as approvals for zootechnical feed additives and improved coordination for approving gene-editing and biotechnology in animals.
Food and Drug Administration Commissioner Robert Califf said the agency plans to soon announce the naming of the new deputy commissioner of human foods as well as unveil its innovation agenda for the Center for Veterinary Medicine.